This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Leadiant sees deadline for Italian non-compliance probe pushed to July

( April 30, 2024, 08:30 GMT | Official Statement) -- MLex Summary: Leadiant Biosciences’ non-compliance proceeding has been postponed to July 1, 2024, from April 30, the Italian Competition Authority has said in its most recent weekly newsletter. In 2022, the company was fined for abusing its dominant position for drugs used to treat erebrotendinous xanthomatosis. The watchdog then started a procedure for non-compliance with the decision. Abstract follows. Case reference is A524B. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections